image
Healthcare - Biotechnology - NASDAQ - US
$ 0.7551
-4.48 %
$ 90.2 M
Market Cap
-0.42
P/E
BALANCE SHEET
229 M ASSETS
-40.19%
51.7 M LIABILITIES
90.14%
177 M EQUITY
-50.15%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Invivyd, Inc.
image
Current Assets 225 M
Cash & Short-Term Investments 201 M
Receivables 933 K
Other Current Assets 23.3 M
Non-Current Assets 4.3 M
Long-Term Investments 0
PP&E 4.12 M
Other Non-Current Assets 175 K
Current Liabilities 50.3 M
Accounts Payable 7.95 M
Short-Term Debt 2.89 M
Other Current Liabilities 39.5 M
Non-Current Liabilities 1.42 M
Long-Term Debt 1.44 M
Other Non-Current Liabilities -22 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020
ASSETS
Cash & Cash Equivalents 200.6 92.1 542.2 115.0
Short Term Investments 0 279.9 49.2 0
Receivables 0.9 0.4 0.2 0
Inventory 0 (0.4) (0.2) 0
Other Current Assets 21.7 8.2 25.1 2.4
Total Current Assets 224.9 376.9 616.7 117.4
PP&E 4.1 6.1 83 K 0
Intangible Assets 0 0 0 0
Goodwill 0 0 0 0
Long Term Investments 0 0 0 0
Other Long Term Assets 0.2 0.2 3.3 0
Other Assets 0 0 0 0
Total Assets 229.2 383.2 620.1 117.4
LIABILITIES
Accounts Payable 8.0 1.5 5.8 8.2
Short Term Debt 2.9 3.1 0 0
Other Current Liabilities 39.5 20.4 56.3 4.9
Total Current Liabilities 50.3 25.0 62.1 13.1
Long Term Debt 1.4 4.3 0 0
Deferred Tax Income 0 0 0 0
Other Liabilities 22 K (2.2) 12 K 169.6
Total Liabilities 51.7 27.2 62.1 182.6
EQUITY
Common Stock 11 K 11 K 11 K 1 K
Retained Earnings (732.1) (533.4) (292.1) (65.3)
Other Accumulative Comprehensive Income/Loss 13 K (0.3) 8 K 0
Total Equity 177.5 356.0 558.0 (65.2)
Total Liabilities and Equity 229.2 383.2 620.1 117.4
SHARES OUTSTANDING
Common Shares Outstanding 109.5 108.3 110.8 111.2